Development and Validation of a Prognostic Signature for Malignant Pleural Mesothelioma.

Published on Feb 15, 2019in Frontiers in Oncology6.244
路 DOI :10.3389/FONC.2019.00078
Jian-Guo Zhou16
Estimated H-index: 16
,
Hua Zhong1
Estimated H-index: 1
(WHU: Wuhan University)
+ 3 AuthorsHu Ma11
Estimated H-index: 11
(Zunyi Medical College)
Sources
Abstract
Introduction: Dysregulated genes play a critical role in the development and progression of cancer, suggesting their potential as novel independent biomarkers for cancer diagnosis and prognosis. Prognostic model-based gene expression profiles are not widely utilized clinically. We investigated the prognostic significance of an expression profile-based gene signature for outcome prediction in patients with malignant pleural mesothelioma (MPM). Methods: The gene expression profiles of a large cohort of patients with MPM were obtained and analyzed by repurposing publicly available microarray data. A gene-based risk score model was developed with the training dataset and then validated with the TCGA-MESO (mesothelioma) dataset. The time-dependent receiver operating characteristic (ROC) curve was used to evaluate the prognostic performance of survival prediction. The biological function of the prognostic genes was predicted using bioinformatics analysis. Results: Three genes in the training dataset (GSE2549) were identified as significantly associated with the overall survival (OS) of patients with MPM and were combined to develop a three-gene prognostic signature to stratify patients into low-risk and high-risk groups. The MPM patients of the training dataset in the low-risk group exhibited longer OS than those in the high-risk group (HR = 0.25, 95% CI = 0.11 to 0.56, P < 0.001). Similar prognostic values for the three-gene signature were observed in the validated TCGA-MESO cohort (HR = 0.53 95% CI = 0.33 to 0.85, P = 0.008). ROC analysis also demonstrated the good performance in predicting 3-year OS in the GEO and TCGA cohorts (KM-AUC for GEO = 0.989, KM-AUC for TCGA = 0.618). The C-statistic for the 3-gene model was 0.761. Validation with TCGA-MESO confirmed the model鈥檚 ability to discriminate between risk groups in an alternative data set with fair performance (C-statistic: 0.68). Functional enrichment analysis suggested that these three genes may be involved in genetic and epigenetic events with known links to MPM. Conclusions: This study has identified and validated a novel 3-gene model to reliably discriminate patients at high and low risk of death in unselected populations of patients with MPM. Further larger, prospective multi-institutional cohort studies are necessary to validate this model.
Figures & Tables
Download
馃摉 Papers frequently viewed together
20201.89Medicine
5 Authors (Jin-Xian Qian, ..., Bo Long)
References37
Newest
#1Hannah Louise Moody (Hull York Medical School)H-Index: 1
#2Michael J. Lind (Hull York Medical School)H-Index: 36
Last. Stephen G. Maher (University of Hull)H-Index: 18
view all 3 authors...
Malignant pleural mesothelioma (MPM) is associated with an聽extremely poor prognosis, and most patients initially are or聽rapidly become unresponsive to platinum-based chemotherapy. MicroRNA-31 (miR-31) is encoded on a genomic fragile site, 9p21.3, which is reportedly lost in many MPM tumors. Based on previous findings in a variety of other cancers, we hypothesized that miR-31 alters chemosensitivity and that miR-31 reconstitution may influence sensitivity to chemotherapeutics in MPM. Reintroducti...
Source
#1Anna Truini (UniGe: University of Genoa)H-Index: 18
#2Simona CocoH-Index: 23
Last. Francesco GrossiH-Index: 42
view all 21 authors...
// Anna Truini 1, 2, * , Simona Coco 1, * , Ernest Nadal 3, 4, 5, * , Carlo Genova 1, 2 , Marco Mora 6 , Maria Giovanna Dal Bello 1 , Irene Vanni 1 , Angela Alama 1 , Erika Rijavec 1 , Federica Biello 1 , Giulia Barletta 1 , Domenico Franco Merlo 7 , Alessandro Valentino 8 , Paola Ferro 8 , Gian Luigi Ravetti 6 , Sara Stigliani 9 , Antonella Vigani 10 , Franco Fedeli 8 , David G. Beer 5 , Silvio Roncella 8 and Francesco Grossi 1 1 Lung Cancer Unit, Ospedale Policlinico San Martino, Genoa, Italy ...
Source
#1Paola Mozzoni (University of Parma)H-Index: 27
#2Luca Ampollini (University of Parma)H-Index: 20
Last. Massimo Corradi (University of Parma)H-Index: 45
view all 11 authors...
Background. The identification of diagnostic/prognostic biomarkers for asbestos-related diseases is relevant for early diagnosis and patient survival and may contribute to understanding the molecular mechanisms underlying the disease development and progression. Aims. To identify a pattern of miRNAs as possible diagnostic biomarkers for patients with malignant pleural mesothelioma (MPM) and asbestosis (ASB) and as prognostic biomarkers for MPM patients. Methods. miRNA-16, miRNA-17, miRNA-126, an...
Source
#1Chiara De Santi (RCSI: Royal College of Surgeons in Ireland)H-Index: 9
#2Ombretta MelaiuH-Index: 13
Last. Stefano Landi (UniPi: University of Pisa)H-Index: 55
view all 18 authors...
Malignant pleural mesothelioma (MPM) is an aggressive human cancer and miRNAs can play a key聽role for this disease. In order to broaden the knowledge in this field, the miRNA expression was investigated in a large series of MPM to discover new pathways helpful in diagnosis, prognosis and therapy. We employed nanoString nCounter system for miRNA profiling on 105 MPM samples and 10 healthy pleura. The analysis was followed by the validation of the most significantly deregulated miRNAs by RT-qPCR i...
Source
#1Luisella Righi (UNITO: University of Turin)H-Index: 34
#2Eleonora Duregon (UNITO: University of Turin)H-Index: 17
Last. Giorgio V. Scagliotti (UNITO: University of Turin)H-Index: 80
view all 12 authors...
Abstract Introduction Malignant pleural mesothelioma (MPM) is a highly aggressive disease with limited therapeutic options. Histological subtype remains among the most reliable prognostic factors, because the epithelioid subtype associated with the best prognosis and the sarcomatoid subtype with the worst. The biphasic subtype has an intermediate prognosis, but its definitive histological diagnosis may be challenging owing to the difficulty of assessing the neoplastic nature of the stromal compo...
Source
#1Anna TruiniH-Index: 18
#2Simona CocoH-Index: 23
Last. Francesco GrossiH-Index: 42
view all 12 authors...
Malignant Pleural Mesothelioma (MPM) is an aggressive disease characterized by a dismal prognosis, mainly due to late diagnosis. To date, there are very few treatment options available and the refractoriness to the majority of therapeutic strategies, leading to consider MPM a relevant problem in public health. Therefore, the identification of novel prognostic markers and alternative therapeutic strategies remain a top priority. Several efforts have been made in this direction and to date a numbe...
Source
#1R. Ryan Meyerhoff (Duke University)H-Index: 14
#2Chi-Fu Jeffrey Yang (Duke University)H-Index: 22
Last. Mark F. Berry (Stanford University)H-Index: 40
view all 8 authors...
Background This study was conducted to determine how malignant pleural mesothelioma (MPM) histology was associated with the use of surgery and survival.
Source
#3Di Wu (Harvard University)H-Index: 97
limma is an R/Bioconductor software package that provides an integrated solution for analysing data from gene expression experiments. It contains rich features for handling complex experimental designs and for information borrowing to overcome the problem of small sample sizes. Over the past decade, limma has been a popular choice for gene discovery through differential expression analyses of microarray and high-throughput PCR data. The package contains particularly strong facilities for reading...
Source
#1Tomomi Hirata (UCSF: University of California, San Francisco)H-Index: 14
#2Qingfeng Zheng (UCSF: University of California, San Francisco)H-Index: 4
Last. Biao He (UCSF: University of California, San Francisco)H-Index: 44
view all 16 authors...
Malignant pleural mesothelioma (MPM) is a highly aggressive tumor that has a poor prognosis, limited treatment options, and a worldwide incidence that is expected to increase in the next decade. We evaluated Wnt7A expression in 50 surgically resected tumor specimens using quantitative PCR. The expression values, were assessed by clinicopathological factors and K-M and Cox鈥檚 regression with OS. The mean level of Wnt7A expression had a significant correlation with International Mesothelioma Intere...
Source
#1Bahil Ghanim (Medical University of Vienna)H-Index: 22
#2Thomas Klikovits (Medical University of Vienna)H-Index: 18
Last. Balazs Hegedus (Semmelweis University)H-Index: 35
view all 24 authors...
Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study
Source
Cited By8
Newest
#1Weicheng Duan (HUST: Huazhong University of Science and Technology)H-Index: 2
#2Kang Wang (HUST: Huazhong University of Science and Technology)H-Index: 2
Last. Bo Xiong (HUST: Huazhong University of Science and Technology)H-Index: 17
view all 7 authors...
Malignant pleural mesothelioma (MPM) is a highly aggressive cancer with short survival time. Unbalanced competing endogenous RNAs (ceRNAs) have been shown to participate in the tumor pathogenesis and served as biomarkers for the clinical prognosis. However, the comprehensive analyses of the ceRNA network in the prognosis of MPM is still rarely reported. In this study, we obtained the transcriptome data of the MPM and the normal samples from TCGA, EGA, and GEO databases and identified the differe...
Source
#1Federica Morani (UniPi: University of Pisa)H-Index: 5
#2Luisa BiscegliaH-Index: 1
Last. Federica GemignaniH-Index: 33
view all 7 authors...
Malignant pleural mesothelioma (MPM) is a fatal tumor lacking effective therapies. The characterization of overexpressed genes could constitute a strategy for identifying drivers of tumor progression as targets for novel therapies. Thus, we performed an integrated gene-expression analysis on RNAseq data of 85 MPM patients from TCGA dataset and reference samples from the GEO. The gene list was further refined by using published studies, a functional enrichment analysis, and the correlation betwee...
Source
#1Xiangxin Zhang (Shihezi University)H-Index: 1
#2Liu Yang (Shihezi University)H-Index: 1
Last. Ming Kong (SDU: Shandong University)H-Index: 1
view all 4 authors...
INTRODUCTION Malignant pleural mesothelioma (MPM) is closely linked to asbestos exposure and is an extremely aggressive tumor with poor prognosis. OBJECTIVE Our study aimed to elucidate hub genes and potential drugs in MPM by integrated bioinformatics analysis. METHODS GSE42977 was download from the Gene Expression Omnibus (GEO) database; the differentially expressed genes (DEGs) with adj.p value <0.05 and |logFC| 鈮2 were identified. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes...
Source
#1Harvey I. Pass (NYU: New York University)H-Index: 122
#2Marjan Alimi (NYU: New York University)H-Index: 2
Last. Chandra Goparaju (NYU: New York University)H-Index: 23
view all 5 authors...
Malignant pleural mesothelioma (MPM) is an asbestos-related neoplasm that can only be treated successfully when correctly diagnosed and treated early. The asbestos-exposed population is a high-risk group that could benefit from sensitive and specific blood- or tissue-based biomarkers. We review recent work with biomarker development in MPM and literature of the last 20 years on the most promising blood- and tissue-based biomarkers. Proteomic, genomic, and epigenomic platforms are covered. SMRP i...
Source
#1Yi-Yang Bai (Xi'an Jiaotong University)H-Index: 3
#2Xiao Wang (Xi'an Jiaotong University)H-Index: 34
Last. Lili Jiang (Xi'an Jiaotong University)H-Index: 16
view all 9 authors...
Malignant pleural mesothelioma (MPM), predominantly caused by asbestos exposure, is a highly aggressive cancer with poor prognosis. The staging systems currently used in clinics is inadequate in evaluating the prognosis of MPM. In this study, a five-gene signature was developed and enrolled into a prognostic risk score model by LASSO Cox regression analysis based on two expression profiling datasets (GSE2549 and GSE51024) from Gene Expression Omnibus (GEO). The five-gene signature was further va...
Source
Source
ABSTRACTMalignant pleural mesothelioma (MPM) is a type of cancer characterized by a short survival time and poor prognosis. Malignant pleural mesothelioma is most frequently associated with exposur...
Source
#1Yun-he Liu (Fudan University)H-Index: 2
#2Ning Yang (SJTU: Shanghai Jiao Tong University)H-Index: 1
Last. Lei Liu (Fudan University)H-Index: 32
view all 6 authors...
Abstract Multiple myeloma is the second largest malignant tumor of the blood system. Proteasome inhibitors (PIs) currently are effective drugs for some myeloma patients, but their prognosis varies. We extracted the transcriptome expression data and clinical information of myeloma patients from MMRF CoMMpass database, and used the Random Survival Forest Variable Hunting (RSF-VH) algorithm to select 6 highly prognosis-related genes and to develop a 6-genes scoring model, by which the risk score pr...
Source
#1Zhe Wang (PRC: China Medical University (PRC))H-Index: 1
#2Zhongmiao Wang (PRC: China Medical University (PRC))H-Index: 1
Last. Baoli Qin (PRC: China Medical University (PRC))H-Index: 1
view all 7 authors...
Background and aim: Lung squamous cell carcinoma (LUSC), is a pathological subtype of lung cancer, accounting for 30% of the lung cancers. A reliable model was constructed, based on the whole gene expression profiles, to predict the prognosis of patients with LUSC. Methods: The RNA-Seq data of LUSC was downloaded from the TCGA database, and differentially expressed genes (p 1) were screened out. By univariate and multivariate Cox regression analysis, we identified seven prognosis-related genes. ...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.